Clinical Trial Update: Real Time 3-Dimensional Stress Echocardiography [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating real-time three-dimensional stress echocardiography for coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Coronary Disease | Phase 2 | Status: COMPLETED